Optimal Timing To Initiate Antiviral Prophylaxis of MTCT: More Required to Be Done

Abstract

Section snippets

Authors' contributions

Ruixuan Hong and Xiaoyun Liu contributed to writing the manuscript. Xueru Yin critically revised the manuscript and reviewed the manuscript for important content. All authors approved the final manuscript submitted.

Financial support

Funding by Science and Technology Projects in Guangzhou (2023A04J2299).

Declaration of Competing Interest

All authors have no conflicts of interest to declare. Please refer to the accompanying ICMJE disclosure forms for further details.

Acknowledgements

We thank all the investigators and participants of the SHIELD program, with the commitment to eliminate HBV MTCT.